rs201808265
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_016239.4(MYO15A):āc.4424T>Cā(p.Ile1475Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000188 in 1,614,194 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000301 AC: 75AN: 249420Hom.: 0 AF XY: 0.000273 AC XY: 37AN XY: 135356
GnomAD4 exome AF: 0.000192 AC: 281AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.000191 AC XY: 139AN XY: 727234
GnomAD4 genome AF: 0.000144 AC: 22AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74490
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Ile1475Thr va riant in MYO15A has been reported by our laboratory in 1 individual with unilate ral auditory neuropathy and a family history of hearing loss. This variant has a lso been reported in ClinVar (Variation ID 228953) and has been identified in 0. 12% (10/10150) of Ashkenazi Jewish chromosomes by the Genome Aggregation Databas e (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs201808265). Although this v ariant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analysis suggest that the p.Ile1475Thr variant may impact the protein, though th is information is not predictive enough to determine pathogenicity. In summary, while the clinical significance of the p.Ile1475Thr variant is uncertain, its fr equency suggests that it is more likely to be benign. ACMG/AMP criteria applied: PP3, BS1_Supporting. -
Inborn genetic diseases Uncertain:1
The c.4424T>C (p.I1475T) alteration is located in exon 12 (coding exon 11) of the MYO15A gene. This alteration results from a T to C substitution at nucleotide position 4424, causing the isoleucine (I) at amino acid position 1475 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at